Choice with Responsibility: Reimagining how we work
At Novartis, our people are our most valuable resource. We want everyone to feel able to be their best selves
Read moreAuthor: Michael Crowe
Novartis receives Piqray® approval in Europe – the first and only targeted medicine for HR+/HER2- advanced breast cancer with a PIK3CA mutation
Piqray (alpelisib) is the only treatment approved specifically to address PIK3CA mutation, underscoring Novartis commitment to reimagining cancer care Approval
Read moreBaxter and Ayogo Announce Partnership for Unique Digital Health Solutions for Home Dialysis
PDF DEERFIELD, Ill. and VANCOUVER, British Columbia - July 29, 2020 Baxter International Inc. (NYSE:BAX), a global innovator in renal
Read moreSanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine | GSK
For media and investors only Issued: London, UK and Paris, France Agreement relates to vaccine candidate using Sanofi’s recombinant protein-based
Read moreGSK delivers Q2 sales of £7.6 billion -2% AER, -3% CER (Pro-forma -10% CER*) | GSK
Emma Walmsley, Chief Executive Officer, GSK said: “The fundamentals of GSK’s business remain strong and we are maintaining good momentum
Read moreBoston Scientific Announces Results For Second Quarter 2020
MARLBOROUGH, Mass., July 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.003 billion during the second quarter
Read moreJul 29,2020 | Chugai Provides an Update on Phase III COVACTA Study of Actemra in Hospitalized Patients with Severe COVID-19 Associated Pneumonia | News | CHUGAI PHARMACEUTICAL CO., LTD.
TOKYO, July 29, 2020 — Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the phase III COVACTA study of Actemra®(tocilizumab) did not
Read moreChange of Her Majesty’s Ambassador to Paraguay
Mr Ramin Navai has been appointed Her Majesty’s Ambassador to the Republic of Paraguay in succession to Mr Matthew Hedges.
Read moreSanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation
Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation Q2 2020 sales results reflect the strong performance of
Read moreRoche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia
COVACTA trial did not meet its primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the
Read moreGovernment further boosts chances of UK receiving COVID-19 vaccine
An additional 60 million doses of a potentially lifesaving COVID-19 vaccine have been secured by the government the agreement with
Read moreGiant leap for UK spaceflight programme as consultation launches
consultation on the rules governing UK spaceflight launches today first ever launch into space could have lift off by the
Read moreDowden: ‘Jump-start’ for UK’s leading creative industries
Government announces new £500 million scheme to kickstart film and television production struggling to secure insurance for Covid-related costs Further
Read morePreventing famine and ensuring unrestricted humanitarian access in Yemen
Well, thank you, Mr President, and thank you to all our briefers. The United Kingdom is extremely concerned that COVID-19
Read moreAmgen Reports Second Quarter 2020 Financial Results
THOUSAND OAKS, Calif., July 28, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2020. Key
Read moreDstl awards £300 million weapons research contract
A contract for the accelerated development of disruptive weapon technologies has been awarded by the Defence Science and Technology Laboratory
Read moreForeign Secretary call with Chinese Foreign Minister - 28 July 2020
The Foreign Secretary spoke to Chinese State Councillor and Minister for Foreign Affairs, Wang Yi, today [28 July] reiterating that
Read more4×4 drivers warned after group spotted driving in river
Several off road vehicles were photographed on a stretch of river in Shropshire and the incident was reported to the
Read moreThird Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients
NORTH CHICAGO, Ill., July 28, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced upadacitinib (15 mg and 30 mg, once
Read moreFarxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease
This announcement contains inside information28 July 2020 07:00 BST Farxiga significantly reduced the worsening of renal function or risk of
Read moreNew Director of Infrastructure, Enterprise and Growth joins the IPA
Today (28 July), Government continues to support it’s ambition for world-class project delivery with the appointment of a new Director
Read moreEISAI AND DeNA TO PROVIDE SMARTPHONE APP “EASIIT APP” THROUGH BUSINESS ALLIANCE AGREEMENT | News Release：2020
Eisai Co., Ltd DeNA Co., Ltd. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and DeNA Co., Ltd.’s
Read moreApplications and complaints to the CAC
Published 17 March 2020 Last updated 28 July 2020 + show all updates 28 July 2020 News Article. 21 July 2020
Read moreUK and India join forces on new £8 million research
The funding awards were announced by Lord (Tariq) Ahmad of Wimbledon, Minister of State for South Asia and the Commonwealth,
Read morePfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
Companies advance nucleoside-modified messenger RNA (modRNA) candidate BNT162b2, which encodes an optimized SARS-CoV-2 full-length spike glycoprotein, at a 30µg dose
Read more